Add BrightSurf on Google Email

Study finds better and safer treatment option than saline solution as IV fluid for emergency department and hospital patients

A new study published in JAMA Network Open found that patients who received lactated Ringer solution instead of normal saline for IV fluids had a lower risk of kidney injury and death. The study, which included nearly 150,000 hospital patients, showed a 2.2% reduced risk of major adverse kidney events.

SourceIntermountain Healthcare·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateJun 29, 2022

New approach to treatment of deadly kidney cancer

A new study from Karolinska Institutet has identified a key mechanism behind treatment resistance in a deadly form of kidney cancer. By increasing mitochondrial content in cancer cells, researchers found that these cells became susceptible to the cancer drug sorafenib. This breakthrough offers hope for more targeted cancer treatments.

SourceKarolinska Institutet·JournalNature Metabolism·DateJun 27, 2022

New study from Indiana University shows patients with chronic kidney disease who have heart attacks should be offered invasive therapy, countering dominant practices

Researchers found that invasive therapy for non-ST segment elevation myocardial infarction in patients with CKD is associated with lower mortality and reduced risk of cardiac events. The study challenges the dominant practice of offering medical management instead of invasive therapy for this population.

SourceIndiana University School of Medicine·JournalJournal of the American Heart Association·DateJun 21, 2022

NUS Medicine researchers discover glaucoma and chronic kidney disease have more in common than what meets the eye

Chronic kidney disease and glaucoma have been found to share common risk factors such as diabetes and hypertension, leading to a higher risk of developing both conditions. The study also reveals that patients with glaucoma are more likely to develop chronic kidney disease over time.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalEClinicalMedicine·TypeMeta-analysis·DateJun 21, 2022

Chinese Medical Journal review explores the role of macrophages in the progression of acute kidney injury to chronic kidney disease

A recent review article highlights the crucial role of macrophages in the progression from acute kidney injury (AKI) to chronic kidney disease (CKD). The study suggests that targeting specific signaling pathways and altering macrophage activation can prevent renal fibrosis and CKD. Therapeutic strategies such as clodronate liposomes an...

SourceCactus Communications·JournalChinese Medical Journal·TypeLiterature review·DateJun 20, 2022

Genetic screening algorithm could identify people with kidney disease risk

A new algorithm can analyze thousands of genomic variants to estimate a person's risk of developing chronic kidney disease, with the highest scores indicating tripled risk compared to the general population. Early detection may prevent many cases of kidney failure and reduce the need for transplant or dialysis.

SourceColumbia University Irving Medical Center·JournalNature Medicine·TypeData/statistical analysis·DateJun 16, 2022

New discoveries in lupus research

Researchers at the University of Houston have identified blood biomarkers predicting heart disease in lupus patients and urine biomarkers for diagnosing kidney inflammation in children with lupus. These findings hold promise for early preventive measures and improved treatment outcomes.

SourceUniversity of Houston·JournalFrontiers in Cardiovascular Medicine·DateJun 2, 2022

COVID kidney injury twice as common as diagnosed

A University of Queensland-led study found that millions of COVID-19 patients may have undiagnosed acute kidney injury (AKI), which can lead to serious illness or death. The true AKI diagnosis rates are likely double existing data, highlighting the need for improved detection and management strategies.

SourceUniversity of Queensland·JournalPLOS Medicine·TypeObservational study·DateJun 2, 2022

Metals found in people’s urine could detect acute kidney injury in very early stages, says new study

Scientists have discovered that certain metals found in people's urine could be potentially useful clinical biomarkers for the early detection of acute kidney injury (AKI). The study, which was led by experts from the University of Nottingham, found that concentrations of these metals rose in urine within an hour after cardiac surgery ...

SourceUniversity of Nottingham·JournalKidney International Reports·TypeExperimental study·DateMay 30, 2022

Kyoto scientists discover ‘crack team’ of kidney cells that are key to disease recovery

Researchers at Kyoto University identify a distinct subpopulation of fibroblasts responsible for producing the hormone erythropoietin (Epo), which stimulates red blood cell production. This discovery provides insight into renal anemia and may lead to novel treatment methods for patients with chronic kidney disease.

SourceKyoto University·JournalKidney International·TypeExperimental study·DateMay 27, 2022

New research questions previous link between diabetes drugs and bone fractures

A recent study published in CJASN found that SGLT-2 inhibitors were not associated with an increased risk of fractures in adults with chronic kidney disease, regardless of their kidney function. The study included over 38,000 new users of the medications and compared them to those prescribed a different diabetes medication.

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateMay 26, 2022

COVID-19 can directly infect and damage human kidney cells

Researchers at Duke University discovered that SARS-CoV-2, the virus causing COVID-19, can directly infect and damage specific types of kidney cells. The virus hijacks the cell's machinery to replicate, leading to structural damage and increased production of viral particles.

SourceDuke University·JournalFrontiers in Cell and Developmental Biology·TypeExperimental study·DateApr 21, 2022

Study: Black kidney transplant patients exhibit faster clearance rates of key immunosuppressive medicine tacrolimus

A new study found that Black kidney transplant recipients exhibit a faster clearance rate of tacrolimus, an immunosuppressive drug. The study suggests that considering both sex and race when dosing tacrolimus may reduce adverse effects and enhance transplant outcomes.

SourceUniversity at Buffalo·JournalPharmacotherapy The Journal of Human Pharmacology and Drug Therapy·DateApr 18, 2022

Low-dose lithium may slow kidney aging

Researchers at The University of Toledo found that low-dose lithium acts as a powerful anti-aging agent in the kidneys by blocking GSK3-beta, an enzyme associated with cellular aging. Studies showed improved kidney function and reduced albuminuria in mice and psychiatric patients treated with lithium.

SourceUniversity of Toledo·JournalJournal of Clinical Investigation·TypeExperimental study·DateApr 12, 2022

The “Deciding Not to Decide” option can improve older adult patient care

A new study suggests including the 'Deciding Not to Decide' treatment option can improve care for older adults with chronic kidney disease, giving them more time to make informed decisions about their treatment. Researchers argue that this approach strengthens patient-centered care and increases patient autonomy.

SourceRutgers University·JournalJournal of the American Society of Nephrology·TypeObservational study·DateMar 16, 2022

Physiological effects of peripheral amyloid-β elucidated - Type 2 diabetes seen as major risk to development of Alzheimer’s disease

Researchers identified peripheral tissues as source of blood amyloid beta, which regulates blood glucose levels and suppresses insulin secretion. The study suggests a possible mechanism linking type 2 diabetes to Alzheimer's disease development.

SourceOsaka City University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 14, 2022

Could a community-based approach to genetic testing help African Americans reduce risks of chronic kidney disease?

Researchers found that a community-based approach to reporting APOL1 genetic test results resulted in lower blood pressure readings among hypertensive patients. This trial suggests that involving communities in genetic testing could be beneficial for reducing the risks of chronic kidney disease.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateMar 4, 2022

Study examines use of palliative care for patients with COVID-19 and acute kidney injury

A new study found that palliative care for hospitalized patients with both COVID-19 and acute kidney injury (AKI) was often called later than expected, despite the high risk of death. Palliative care supports primary doctors in managing emotional and physical symptoms while assisting in advance care planning.

SourceAmerican Society of Nephrology·JournalClinical Journal of the American Society of Nephrology·DateFeb 24, 2022

Obesity may increase end-stage kidney disease risk in women with type 2 diabetes

A new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that obesity may increase the risk of end-stage kidney disease in women with type 2 diabetes. Managing blood pressure and sugar levels is not enough to slow progression, emphasizing the need for weight management.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology and Metabolism·DateFeb 22, 2022